Disparities Details by Geographic Location for 2017
IID-7.4 : Children receiving 1+ doses of MMR vaccine by age 19–35 months (percent)
This chart compares rates by population.
Error Bar (I) represents the 95% confidence interval.
Additional footnotes may apply to these data. Please refer to footnotes below the data table for further information.
See also Disparities Overview by Geographic Location for IID-7.4
IID-7.4 Maintain an effective coverage level of 1 dose of measles-mumps-rubella (MMR) vaccine among children by age 19 to 35 months
Children receiving 1+ doses of MMR vaccine by age 19–35 months (percent)
Data are subject to revision and may have changed since a previous release.
Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.
Data are not available or not collected for populations not shown.
CI: 95% confidence interval.
- The better group rate for this objective, 91.7%, was attained by persons living in a metropolitan area.
- The worse group rate for this objective, 89.9%, was attained by persons living in a non-metropolitan area.
- The absolute difference (or range) between the best and worst group rates was 1.8 percentage points.
- The best group rate was <1.100 times the worst group rate.
Persons living in a metropolitan area achieved the better group rate for this objective, 91.7%.
The better group rate was <1.1 times the rate among persons living in a non-metropolitan area.